A.T.P. 2
$23.99
A.T.P. 2 s a dual-bottle injectable solution designed to enhance energy metabolism, oxygenation, and cardiac performance in horses and camels. Combining ATP, DNA, B-complex vitamins, glutathione, and nicotinamide, it supports recovery from heart failure, muscular dysfunction, and circulatory irregularities. Learn about its slow IV administration, synergistic formula, and race-day readiness benefits.
A.T.P. 2
Energetic-oxygenator-myocardiotonic
Preparation of equestrian tests and in all cases where it is necessary to increase the capacity of work and performance. In heart failure. Progressive muscle therapy, subacute and chronic polyarthritis, peripheral circulatory irregularities, thrombophlebitis, humeral-scapular periarthritis.
A.T.P. 2 Presentation:
Box containing 1 bottle No. 1 and 1 bottle No. 2
A.T.P. 2 Dose:
HORSES: 10ml. By slow intravenous route, day by day.
Dissolve the contents of bottle # 1 with # 2.
LOW ENDOVENOUS VIA
Formula:
Deoxyribonucleic acid-A.T.P.-Vitamin B
Bottle # 1
ATP 0.500 grs.
(Adenosine-5-Trisphosphate Acid)
Bottle # 2
DNA (Deoxyribonucleic acid) 1 g.
Vitamin B12 10000 grs.
Vitamin B1 (Thiamine Chlorine) 0.500 grs.
Vitamin B2 (Riboflavin) 0.500 grs.
Vitamin B6 (Pyridoxine Chloride) 0.350 g.
Vitamin B15 (Dichloroethanoate)
-D-isopropyl ammonium) 0.200 g.
Glutathione reduced 0.100 grs.
Nicotinamide 2 grs.
Glucose pure anhydrous 25 grs.
Alcohol Benzyl 2 grs.
Tris-distilled water
Apirogena Sterile 100 grs.
Related products
12P15 – 10 ML
Adequan Canine For Sale
Amino-Lite 250 ml
Amp Injections
antoplex injection
Regenex Gold
- Regenex Gold
- An advanced injectable solution for equine joint health and tissue repair.
- Unique blend of Hyaluronic Acid (HA), Anti Obesity Drug Peptide (AOD), and Polymer IA.
- Improves cartilage quality, joint fluid lubrication, and reduces inflammation.
- Actively promotes stem cell dislodgement for connective tissue and bone repair.
- Ideal for arthritic horses and enhancing performance.
- Available in 10mL vials.

Reviews
There are no reviews yet.